Silence Therapeutics plc (SLNCF)
OTCMKTS
· Delayed Price · Currency is USD
1.450
0.00 (0.00%)
Sep 25, 2025, 8:00 PM EDT
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $261.68 million as of September 29, 2025. Its market cap has decreased by -69.87% in one year.
Market Cap
261.68M
Enterprise Value
147.52M
Revenue
27.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.45
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from 538.37M to 261.68M, a decrease of -51.39%. That is a compound annual growth rate of -13.31%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 26, 2025 | 261.68M | -19.44% |
Dec 31, 2024 | 324.84M | -51.64% |
Dec 29, 2023 | 671.70M | 22.71% |
Dec 30, 2022 | 547.37M | -23.44% |
Dec 31, 2021 | 714.99M | 17.04% |
Dec 31, 2020 | 610.91M | 13.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Veradigm | 789.71M |
Elite Pharmaceuticals | 742.59M |
Tian'an Technology Group | 718.73M |
Glass House Brands | 516.60M |
Northwest Biotherapeutics | 387.17M |
CytoDyn | 332.57M |
American Oncology Network | 305.31M |
Nika Pharmaceuticals | 301.74M |